Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Intervacc AB | 500,000 | net | 27 Feb 2026 | tx 3+500,000 |
| Vicore Pharma Holding AB | -177,981 | net | 16 Sept 2021 | tx 4+300,000−477,981 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | PURCHASE | Intervacc AB | 200,000 | 0.62 SEK | |
| 20 Feb 2026 | PURCHASE | Intervacc AB | 100,000 | 0.75 SEK | |
| 18 Feb 2026 | PURCHASE | Intervacc AB | 200,000 | 0.75 SEK | |
| 16 Sept 2021 | GRANT_AWARD | Vicore Pharma Holding AB | 100,000 | 0.00 SEK | deriv |
| 06 Oct 2020 | GRANT_AWARD | Vicore Pharma Holding AB | 100,000 | 0.00 SEK | deriv |
| 15 Oct 2019 | GRANT_AWARD | Vicore Pharma Holding AB | 100,000 | 0.00 SEK | deriv |
| 27 Sept 2018 | SALE | Vicore Pharma Holding AB | 477,981 | 2.00 SEK | deriv |